Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-24-060262

Chief Science & Business Off bought 500 shares at $6.29 ($3,145)

From the SEC's structured data for this filing

Trades in this filing

Poradosu Enrique · Chief Science & Business Off

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-10 Purchase : show line 1 in the form +500 $6.29 $3,145 1,504,319 D
Open-market purchases · 500 sh · avg $6.29 · $3,145
Loading xslF345X05/tm2414233-2_4seq1.xml…